As of July 27, 2024, Healthcaps India Ltd., Unlisted Shares are trading at ₹180.00 per share, with a 52-week high of ₹180 and 52-week low of ₹180. The minimun lot size is 1115 shares, and the shares are traded on NSDL and CDSL.
ISIN
INE936K01016
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
₹ 10
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Share
40,37,190
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Total Income
₹ 246.36 undefined
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
Profit After Tax
₹ ****
It is the final profit left over after subtracting all operating and non operating items from net revenue.
EPS
₹ ****
It is the profit allocated to each outstanding share of common stock.
P/E
****
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
P/B
****
It shows the relationship between the current price and the book value of each share. A lower P/B ratio can mean that the stock is undervalued.
Market Capitalisation
₹ 72.67 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Enterprise Value
₹ ****
It measures companys total value, which includes market capitalization, debt and excludes cash.
Book Value
₹ 368.12
It calculates the per share value of a company based on its equity available to common shareholders
Intrinsic Value
₹ ****
Intrinsic value is the anticipated value of a company or stock determined through fundamental analysis. It is also referred to as the price a rational investor is willing to pay for an investment, given its level of risk.
Earnings Yield
41.03 %
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Pharmaceuticals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Delisted
Category is defined as a class or division of things regarded as having particular shared characteristics.
Cashflow - Operations
₹ 20.4
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
Cashflow - Financing
₹ 0.84
It shows the net flows of cash that are used to fund the company, which include transactions involving debt, equity, and dividends.
Healthcaps India Ltd. Growth
Compounded Sales Growth
1 Year
3 Year
7 Year
Compounded Profit Growth
1 Year
3 Year
7 Year
Return On Equity
2017
2020
2023
Highlights
Leader in Empty Capsule Manufacturing - HealthCaps India Ltd ("HIL") has been manufacturing Empty Hard Gelatin Capsule Shells for over two decades. These capsules are widely used to encapsulate drugs, vitamins, antibiotics, etc. It also manufactures BSE/TSE-free EHG Capsules using EDQM-approved gelatin. The installed capacity of Empty Hard Gelatin Capsule in India is 100 billion capsules per annum. Healthcaps India leads the market with an installed capacity of 19 billion capsules annually.
Revenue Growth - In FY22, the company saw a substantial increase due to COVID-19, whereas in FY3, the company's revenue experienced a subtle decrease, declining from ₹255 Cr in FY22 to ₹246 Cr in FY23, indicating a decline rate of -3.4%. Over the past five years, the company's revenue has substantially increased, achieving a compound annual growth rate (CAGR) of 24.6% from FY18 to FY23.
Profitability - The company's profitability has consistently improved over time. The EBIT margin, which was 13.2% in FY18, has risen to 15.9% in FY23, reflecting a compound annual growth rate (CAGR) of 3.9%. Likewise, the net profit margin of the company has increased from 8.1% in FY18 to 12.1% in FY23, demonstrating a CAGR of 8.4% from FY18 to FY23.
Investment Thesis - Healthcaps India holds the leading position with an installed capacity of 19 billion capsules annually. Listed competitors are trading at an average P/E ratio of 12.5x. With a discount for lack of marketability (DLOM) ranging from 30% to 50%, the anticipated share price for Healthcaps is projected to fall within the range of ₹450 to ₹650. Considering the current share price at ₹180, the stock is deemed undervalued, presenting investors with a compelling investment opportunity with potential returns ranging from 3x to 4x.
Share Cancellation - As of 21st July 2023, the company has 16,451 public shareholders holding 9,23,860 equity shares. The company has passed a special resolution to reduce the issued, subscribed, and paid-up equity share capital of the company from 40,37,190 equity shares of ₹10 each to 32,13,330 equity shares of ₹10 each by canceling and extinguishing 9,23,860 equity shares of ₹10 each, collectively held by the shareholders of the company by paying a sum of ₹273.58 per equity share, so canceled and extinguished. These shareholders are those who had not accepted exit at the time of delisting or have become shareholders through private dealings / off-market dealings amongst public shareholders.